Create account

Coverage dated December 19, 2024 to December 22, 2024

FDA approves weight-loss drug for obstructive sleep apnea

Headline from WMUR, from the development of Dec 20, 2024

Newest development Dec 23, 2024 · 2 reportsSleep Apnea Device Maker Stocks Slide on FDA Ruling for Eli Lilly's Zepbound

The U.S. Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the weight-loss drug Zepbound.

WMUR's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Developments in this update

2 dated developments, oldest first, newest marked. Each is named by one outlet's own headline; open its reports to see every outlet that covered it.

  1. Names this update

    FDA approves weight-loss drug for obstructive sleep apnea

    Headline from WMUR ·

  2. Newest

    Sleep Apnea Device Maker Stocks Slide on FDA Ruling for Eli Lilly's Zepbound

    Headline from Investopedia ·

Read the reports

Reports & sources

37 articles, oldest first.

  1. NBC New York

    FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S. (opens NBC New York)

    Published

    NBC New York's feed description

    The agency's decision expands the use of Zepbound and could potentially pave the way for Eli Lilly to gain broader insurance coverage for the treatment.

  2. CNN

    FDA approves weight-loss drug Zepbound for obstructive sleep apnea (opens CNN)

    Published

    CNN's feed description

    The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the weight-loss drug Zepbound.

  3. Quartz

    The FDA just approved Eli Lilly's Zepbound for sleep apnea — and Medicare coverage could be next (opens Quartz)

    Published

    Quartz's feed description

    Zepbound was found to be five times more effective than a placebo in reducing breathing disruptions for people with obstructive sleep apnea

  4. Time

    The First Sleep Apnea Drug Is Here (opens Time)

    Published

    Time's feed description

    Zepbound isn't just for obesity. The FDA approved the weight-loss drug for sleep apnea, Lilly says.

  5. Forbes

    Zepbound Approved For Sleep Apnea (opens Forbes)

    Published

    Forbes's feed description

    An estimated 39 million American adults suffer from obstructive sleep apnea, a condition in which the upper airway is blocked while sleeping.

  6. ABC 7 San Francisco

    FDA approves Eli Lilly's obesity medication for obstructive sleep apnea (opens ABC 7 San Francisco)

    Published

    ABC 7 San Francisco's feed description

    The FDA has expanded the approval of Eli Lilly's obesity medication Zepbound to include treating moderate to severe obstructive sleep apnea.

  7. Honolulu Star-Advertiser

    New weight-loss treatment becomes first FDA-approved drug for sleep apnea | Honolulu Star-Advertiser (opens Honolulu Star-Advertiser)

    Published

    Honolulu Star-Advertiser's feed description

    The Food and Drug Administration today approved Eli Lilly’s weight-loss treatment, Zepbound, for obstructive sleep apnea, making it the first drug greenlighted to directly treat patients with the common sleeping disorder.

  8. Wyoming Public Media

    FDA approves weight loss drug Zepbound to treat obstructive sleep apnea (opens Wyoming Public Media)

    Published

    Wyoming Public Media's feed description

    The FDA said studies have shown that by aiding weight loss, Zepbound improves sleep apnea symptoms in some patients.

  9. Investor's Business Daily

    Eli Lilly's Obesity Drug Wins Approval In Sleep Apnea (opens Investor's Business Daily)

    Published

    Investor's Business Daily's feed description

    Eli Lilly gained FDA approval late Friday for its weight-loss drug, Zepbound, as a treatment for obstructive sleep apnea.

  10. NBC News

    FDA approves weight loss drug Zepbound for sleep apnea (opens NBC News)

    Published

    NBC News's feed description

    Zepbound, Eli Lilly’s weight loss drug, can now be used to treat obstructive sleep apnea in adults with obesity, the FDA said.

  11. UPI

    FDA approves weight-loss drug Zepbound to treat sleep apnea (opens UPI)

    Published

    UPI's feed description

    Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been approved by the Food and Drug Administration for treating moderate to severe obstructive sleep apnea.

  12. Washington Examiner

    FDA approves anti-obesity drug as first sleep apnea medication (opens Washington Examiner)

    Published

    Washington Examiner's feed description

    The US FDA approved Eli Lilly's Zepbound as the first ever medication for obstructive sleep apnea for patients who also have obesity

  13. FOX 4 Dallas

    FDA approves Zepbound, a weight loss drug, to treat obstructive sleep apnea (opens FOX 4 Dallas)

    Published

    FOX 4 Dallas's feed description

    Zepbound, a popular weight loss drug, has become the first FDA-approved prescription medication to treat obstructive sleep apnea.

  14. WSVN Miami

    FDA approves weight-loss drug Zepbound for obstructive sleep apnea - WSVN 7News | Miami News, Weather, Sports (opens WSVN Miami)

    Published

    WSVN Miami's feed description

    (CNN) — The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the weight-loss drug Zepbound.The medicine, part of

  15. WMUR

    FDA approves weight-loss drug for obstructive sleep apnea (opens WMUR)

    Published

    WMUR's feed description

    The U.S. Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the weight-loss drug Zepbound.

  16. Investopedia

    Lilly Rises on FDA Approval of Weight-Loss Drug-Zepbound for Sleep Apnea (opens Investopedia)

    Published

    Investopedia's feed description

    Eli Lilly stock rose Monday after Zepbound received Food and Drug Administration (FDA) approval as a treatment for obstructive sleep apnea among adults with obesity.

  17. Investopedia

    Sleep Apnea Device Maker Stocks Slide on FDA Ruling for Eli Lilly's Zepbound (opens Investopedia)

    Published

    Investopedia's feed description

    Shares of ResMed and Inspire Medical Systems fell after the FDA approved Eli Lilly's weight-loss drug Zepbound to treat moderate-to-severe obstructive sleep apnea in adults with obesity.

  18. Gizmodo

    Popular Weight Loss Drug Zepbound Gains FDA Approval to Treat Sleep Apnea (opens Gizmodo)

    Published

    Gizmodo's feed description

    The FDA has approved Eli Lilly's Zepbound to treat moderate to severe obstructive sleep apnea in adults with obesity.

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.

FDA approves weight-loss drug for obstructive sleep apnea | Since Then